Portfolio Companies 2026 for Roche Venture Fund: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Roche Venture Fund accounts for 24 tracked companies with verified cap-table data, 24 of which disclose round sizes totalling $5.2B. The median disclosed raise is $114M, and the largest is Vaxcyte at $2.4B, ahead of Endeavor BioMedicines ($292M) and Arch Oncology ($241M).
The names that recur most often on these portfolio cap tables are Roche Venture Fund (24 companies), 5AM Ventures (5 companies), Sofinnova Partners (4 companies), Versant Ventures (3 companies), Novo Holdings (3 companies), Ysios Capital (3 companies). By latest disclosed round, the market skews Series A (12), Series B (6), Series C (3), IPO (1).
Companies tracked: 24
Disclosed funding total: $5.2B across 24 companies
Median disclosed raise: $114M
Largest raise: Vaxcyte — $2.4B
Stage mix: Series A 12 · Series B 6 · Series C 3 · IPO 1
